Interaction of amelogenin with hydroxyapatite crystals: an adherence effect through amelogenin molecular self-association
- PMID: 9715666
- DOI: 10.1002/(SICI)1097-0282(19981005)46:4<225::AID-BIP4>3.0.CO;2-R
Interaction of amelogenin with hydroxyapatite crystals: an adherence effect through amelogenin molecular self-association
Abstract
At the secretory stage of tooth enamel formation the majority of the organic matrix is composed of amelogenin proteins that are believed to provide the scaffolding for the initial carbonated hydroxyapatite crystals to grow. The primary objective of this study was to investigate the interaction between amelogenins and growing apatite crystals. Two in vitro strategies were used: first, we examined the influence of amelogenins as compared to two other macromolecules, on the kinetics of seeded growth of apatite crystals; second, using transmission electron micrographs of the crystal powders, based on a particle size distribution study, we evaluated the effect of the macromolecules on the aggregation of growing apatite crystals. Two recombinant amelogenins (rM179, rM166), the synthetic leucine-rich amelogenin polypeptide (LRAP), poly(L-proline), and phosvitin were used. It was shown that the rM179 amelogenin had some inhibitory effect on the kinetics of calcium hydroxyapatite seeded growth. The inhibitory effect, however, was not as destructive as that of other macromolecules tested. The degree of inhibition of the macromolecules was in the order of phosvitin > LRAP > poly(L-proline) > rM179 > rM166. Analysis of particle size distribution of apatite crystal aggregates indicated that the full-length amelogenin protein (rM179) caused aggregation of the growing apatite crystals more effectively than other macromolecules. We propose that during the formation of hydroxyapatite crystal clusters, the growing apatite crystals adhere to each other through the molecular self-association of interacting amelogenin molecules. The biological implications of this adherence effect with respect to enamel biomineralization are discussed.
Similar articles
-
Interactions of amelogenins with octacalcium phosphate crystal faces are dose dependent.Calcif Tissue Int. 2004 Jun;74(6):522-31. doi: 10.1007/s00223-002-0011-3. Calcif Tissue Int. 2004. PMID: 15354860
-
Modification of calcium-phosphate coatings on titanium by recombinant amelogenin.J Biomed Mater Res A. 2003 Mar 1;64(3):483-90. doi: 10.1002/jbm.a.10401. J Biomed Mater Res A. 2003. PMID: 12579562
-
Analysis of hydroxyapatite surface coverage by amelogenin nanospheres following the Langmuir model for protein adsorption.Calcif Tissue Int. 2003 May;72(5):599-603. doi: 10.1007/s00223-002-1099-1. Epub 2003 Apr 17. Calcif Tissue Int. 2003. PMID: 12704567
-
Assembly of amelogenin proteolytic products and control of octacalcium phosphate crystal morphology.Connect Tissue Res. 2003;44 Suppl 1:58-64. Connect Tissue Res. 2003. PMID: 12952175 Review.
-
Amelogenin supra-molecular assembly in vitro compared with the architecture of the forming enamel matrix.Cells Tissues Organs. 2005;181(3-4):202-18. doi: 10.1159/000091382. Cells Tissues Organs. 2005. PMID: 16612086 Review.
Cited by
-
Interactions of amelogenin with phospholipids.Biopolymers. 2015 Feb;103(2):96-108. doi: 10.1002/bip.22573. Biopolymers. 2015. PMID: 25298002 Free PMC article.
-
The nucleation and growth of calcium phosphate by amelogenin.J Cryst Growth. 2007 Jun 15;304(2):407-415. doi: 10.1016/j.jcrysgro.2007.02.035. J Cryst Growth. 2007. PMID: 19079557 Free PMC article.
-
Amelogenin-collagen interactions regulate calcium phosphate mineralization in vitro.J Biol Chem. 2010 Jun 18;285(25):19277-87. doi: 10.1074/jbc.M109.079939. Epub 2010 Apr 19. J Biol Chem. 2010. PMID: 20404336 Free PMC article.
-
Structure, orientation, and dynamics of the C-terminal hexapeptide of LRAP determined using solid-state NMR.J Phys Chem B. 2008 Dec 25;112(51):16975-81. doi: 10.1021/jp808012g. J Phys Chem B. 2008. PMID: 19368031 Free PMC article.
-
Effect of phosphorylation on the interaction of calcium with leucine-rich amelogenin peptide.Eur J Oral Sci. 2011 Dec;119 Suppl 1(Suppl 1):97-102. doi: 10.1111/j.1600-0722.2011.00900.x. Eur J Oral Sci. 2011. PMID: 22243234 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources